For instance, JHU‐083 was shown to significantly suppress tumor growth in a xenograft mouse model by reducing both oxidative and glycolytic metabolism in cancer cells while simultaneously enhancing CD8+ T‐cell function [13]. The gene discussed is CD8A; the disease is neoplasm.